Sheeno Thyparambil, PhD, is the Senior Director of Proteomics Innovation at AstraZeneca, specializing in precision medicine, clinical diagnostics, and oncology. They previously held positions as Principal Scientist at NantOmics, LLC, and Senior Scientist at OncoplexDx, where they contributed to the development of clinical diagnostic tests and managed significant projects in proteomics. With experience as a Graduate Research Assistant at the National Center for Toxicological Research/FDA, they researched early biomarkers for hepatocellular carcinoma and authored a book chapter in "Current Clinical Oncology." Sheeno earned their PhD in Biochemistry and Molecular Biology from the University of Arkansas for Medical Sciences in 2008.
This person is not in the org chart
This person is not in any teams
This person is not in any offices